The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Thermosensitive liposomes for localized delivery and triggered release of chemotherapy
Open accessAbstract
Liposomes are a promising class of nanomedicine with the potential to provide site-specific chemotherapy, thus improving the quality of cancer patient care. First-generation liposomes have emerged as one of the first nanomedicines used clinically for localized delivery of chemotherapy. Second-generation liposomes, i.e. stimuli-responsive liposomes, have the potential to not only provide site-specific chemotherapy, but also triggered drug release and thus greater spatial and temporal control of therapy. Temperature-sensitive liposomes are an especially attractive option, as tumors can be heated in a controlled and predictable manner with external energy sources. Traditional thermosensitive liposomes are composed of lipids that undergo a gel-to-liquid phase transition at several degrees above physiological temperature. More recently, temperature-sensitization of liposomes has been demonstrated with the use of lysolipids and synthetic temperature-sensitive polymers. The design, drug release behavior, and clinical potential of various temperature-sensitive liposomes, as well as the various heating modalities used to trigger release, are discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476 · cited 1×
“Delivery vehicles large enough (>5–6 nm [25]) to escape renal clearance but small enough (<150 nm, in the case of neutral or slightly negatively charged lipid-based carriers [26,27]) to exploit this EPR effect can be used to increase drug bioavailability and reduce off-target toxicities associated with systemic admini…”
BackgroundNanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · cited 1×
“Delivery vehicles large enough (>5–6 nm [25]) to escape renal clearance but small enough (<150 nm, in the case of neutral or slightly negatively charged lipid-based carriers [26,27]) to exploit this EPR effect can be used to increase drug bioavailability and reduce off-target toxicities associated with systemic admini…”
BackgroundTargeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · cited 1×
“These toxic effects restrict the dosages administered to patients, and cancers that survive these lower dosages oftentimes develop a resistance to chemotherapy, making it much more difficult to eradicate the tumors and save the patient [3].”
BackgroundNanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Thermal dose determination in cancer therapy
Sapareto, S. A., & Dewey, W. C. (1984) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(84)90379-1 · Cited by 2,498
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Berg, H. C. (2025) · Princeton University Press eBooks · doi:10.1515/9780691279886 · Cited by 2,367
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Hyperthermia in combined treatment of cancer
Wust, P., Hildebrandt, B., Sreenivasa, G., Rau, B., Gellermann, J., Riess, H., Felix, R., & Schlag, P. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00818-5 · Cited by 1,998
Bangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,809
Allen, T. M., Hansen, C., Martin, F., Redemann, C., & Yau-Young, A. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,391
Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X., & Dai, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1468 · Cited by 1,348
Thermoresponsive Polymers for Biomedical Applications
Ward, M. A., & Georgiou, T. K. (2011) · Polymers · doi:10.3390/polym3031215 · Cited by 1,158
Papahadjopoulos, D., Jacobson, K., Nir, S., & Isac, I. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90314-3 · Cited by 997
Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia
Yatvin, M. B., Weinstein, J. N., Dennis, W. H., & Blumenthal, R. (1978) · Science · doi:10.1126/science.364652 · Cited by 956
Sterically stabilized liposomes
Woodle, M. C., & Lasic, D. D. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90038-c · Cited by 954
Folkman, J., & Shing, Y. (1992) · PubMed · Cited by 789
Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000) · PubMed · Cited by 746
Dvorak, H. F., Nagy, J. A., Dvorák, J., & Dvořàk, A. M. (1988) · PubMed Central · Cited by 679
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong, G., Braun, R. D., & Dewhirst, M. W. (2000) · PubMed · Cited by 633
Majoros, I. J., Myc, A., Thomas, T., Mehta, C. B., & Baker, J. R. (2006) · Biomacromolecules · doi:10.1021/bm0506142 · Cited by 596
Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575
Needham, D., & Dewhirst, M. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00233-2 · Cited by 570
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
Kopecek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00075-8 · Cited by 562
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
Extracellular pH distribution in human tumours
Engin, K., Leeper, D. B., Cater, J. R., Thistlethwaite, A. J., Tupchong, L., & McFarlane, J. D. (1995) · International Journal of Hyperthermia · doi:10.3109/02656739509022457 · Cited by 530
Fundamentals and Applications of Controlled Release Drug Delivery
(2012) · Springer eBooks · doi:10.1007/978-1-4614-0881-9 · Cited by 521
Harris, L., Batist, G., Belt, R., Rovira, D., Navari, R., Azarnia, N., Welles, L., Winer, E., & TLC D‐99 Study Group (2002) · Cancer · doi:10.1002/cncr.10201 · Cited by 512
Polymeric nanomedicine for cancer therapy
Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506
Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D., & Dewhirst, M. W. (2000) · PubMed · Cited by 505
Dromi, S., Frenkel, V., Luk, A., Traughber, B., Angstadt, M., Bur, M., Poff, J., Xie, J., Libutti, S. K., Li, K. C. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2443 · Cited by 492
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Manzoor, A. A., Lindner, L. H., Landon, C. D., Park, J.-Y., Simnick, A. J., Dreher, M. R., Das, S., Hanna, G., Park, W., Chilkoti, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1683 · Cited by 459
Perez & Brady's Principles and Practice of Radiation Oncology
Small, W. (2013) · Cited by 443
Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature.
Kong, G., Braun, R. D., & Dewhirst, M. W. (2001) · PubMed · Cited by 442
Gill, P. S., Wernz, J., Scadden, D. T., Cohen, P., Mukwaya, G. M., von Roenn, J. H., Jacobs, M., Kempin, S., Silverberg, I., Gonzales, G., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.8.2353 · Cited by 438
Yin, X., Hoffman, A. S., & Stayton, P. S. (2006) · Biomacromolecules · doi:10.1021/bm0507812 · Cited by 416
Emerging applications of polymersomes in delivery: From molecular dynamics to shrinkage of tumors
Discher, D. E., Ortiz, V., Srinivas, G., Klein, M. L., Kim, Y., Christian, D., Cai, S., Photos, P., & Ahmed, F. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.011 · Cited by 378
Liposomes and Local Hyperthermia: Selective Delivery of Methotrexate to Heated Tumors
Weinstein, J. N., Magin, R. L., Yatvin, M. B., & Zaharko, D. S. (1979) · Science · doi:10.1126/science.432641 · Cited by 363
Gregoriadis, G., & Ryman, B. E. (1972) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1972.tb19710.x · Cited by 345
Takei, Y. G., Aoki, T., Sanui, K., Ogata, N., Sakurai, Y., & Okano, T. (1994) · Macromolecules · doi:10.1021/ma00099a035 · Cited by 345
Allen, T. M., Austin, G. A., Chonn, A., Lin, L., & Lee, K. C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90268-d · Cited by 345
Multifunctional Micellar Nanomedicine for Cancer Therapy
Blanco, E., Kessinger, C. W., Sumer, B. D., & Gao, J. (2009) · Experimental Biology and Medicine · doi:10.3181/0808-mr-250 · Cited by 332
de Smet, M., Heijman, E., Langereis, S., Hijnen, N. M., & Grüll, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.036 · Cited by 330
Eliaz, R. E., & Szoka, F. C. (2001) · PubMed · Cited by 330
Ultrasound triggered release of cisplatin from liposomes in murine tumors
Schroeder, A., Honen, R., Turjeman, K., Gabizon, A., Kost, J., & Barenholz, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.007 · Cited by 305
Thermosensitive polymer-modified liposomes
Kono, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00204-6 · Cited by 303
pH-Sensitive liposomes-principle and application in cancer therapy
Karanth, H., & Murthy, R. S. R. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.4.0001 · Cited by 294
Perez and Brady's Principles and Practice of Radiation Oncology
Shimm, D. S. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.07.047 · Cited by 293
Iwai, K., Maeda, H., & Konno, T. (1984) · PubMed · Cited by 284
Landon, C. D. (2011) · The Open Nanomedicine Journal · doi:10.2174/1875933501103010038 · Cited by 281
Ponce, A. M., Viglianti, B. L., Yu, D., Yarmolenko, P. S., Michelich, C. R., Woo, J., Bally, M. B., & Dewhirst, M. W. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk005 · Cited by 273
Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks
Gaber, M. H., Wu, N. Z., Hong, K., Huang, S. K., Dewhirst, M. W., & Papahadjopoulos, D. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00389-6 · Cited by 271
Ranjan, A., Jacobs, G. C., Woods, D. L., Negussie, A. H., Partanen, A., Yarmolenko, P. S., Gacchina, C. E., Sharma, K. V., Frenkel, V., Wood, B. J., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.011 · Cited by 267 · cited 2×
“In rat [140] and rabbit [141] experiments, tumors in treatment groups receiving both MRgFUS and drug-loaded liposome demonstrated the greatest uptake of drug when compared to controls (liposome only and/or free drug).”
BackgroundColombo, R., Da Pozzo, L. F., Salonia, A., Rigatti, P., Leib, Z., Baniel, J., Caldarera, E., & Pavone-Macaluso, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.089 · Cited by 267
Phototriggering of liposomal drug delivery systems
Shum, P., Kim, J.-M., & Thompson, D. H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00232-0 · Cited by 255
Koning, G. A., Eggermont, A. M. M., Lindner, L. H., & ten Hagen, T. L. M. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0154-2 · Cited by 254
Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance
de Smet, M., Langereis, S., den Bosch, S. V., & Grüll, H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.002 · Cited by 240
Mills, J. K., & Needham, D. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.08.007 · Cited by 236
Nanotechnology for Cancer Therapy
(2006) · CRC Press eBooks · doi:10.1201/9781420006636 · Cited by 235
Heebner, G., & Gwynne, P. H. (2002) · Science · Cited by 220
Beauchamp, C. O., Gonias, S. L., Menapace, D. P., & Pizzo, S. V. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90131-8 · Cited by 207
Gaber, M. H., Hong, K., Huang, S. K., & Papahadjopoulos, D. (1995) · Pharmaceutical Research · doi:10.1023/a:1016206631006 · Cited by 206
Nanotechnology platforms and physiological challenges for cancer therapeutics
Kim, K. Y. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.12.002 · Cited by 201
Anyarambhatla, G. R., & Needham, D. (1999) · Journal of Liposome Research · doi:10.3109/08982109909035549 · Cited by 199
Huang, S. K., Stauffer, P. R., Hong, K., Guo, J., Phillips, T. L., Huang, A., & Papahadjopoulos, D. (1994) · PubMed · Cited by 183
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Durieux, B., Löffler, K., Fechtner, M., Röhl, T., Fisch, G., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302778 · Cited by 183
Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
Duncan, R., Vicent, M. J., Greco, F., & Nicholson, R. I. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01045 · Cited by 179
Yakushiji, T., Sakai, K., Kikuchi, A., Aoyagi, T., Sakurai, Y., & Okano, T. (1998) · Langmuir · doi:10.1021/la980090+ · Cited by 174
Seynhaeve, A. L. B., Hoving, S., Schipper, D., Vermeulen, C. E., aan de Wiel-Ambagtsheer, G., van Tiel, S. T., Eggermont, A. M. M., & ten Hagen, T. L. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1599 · Cited by 173
Negussie, A. H., Yarmolenko, P. S., Partanen, A., Ranjan, A., Jacobs, G., Woods, D., Bryant, H., Thomasson, D., Dewhirst, M. W., Wood, B. J., et al. (2011) · International Journal of Hyperthermia · doi:10.3109/02656736.2010.528140 · Cited by 169
Kono, K., Ozawa, T., Yoshida, T., Ozaki, F., Ishizaka, Y., Maruyama, K., Kojima, C., Harada, A., & Aoshima, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.045 · Cited by 167
Handbook of cancer chemotherapy
(1993) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(93)90321-b · Cited by 158
Hauck, M., LaRue, S. Μ., Petros, W. P., Poulson, J. M., Yu, D., Spasojević, I., Pruitt, A. F., Klein, A., Case, B. C., Thrall, D. Ε., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0226 · Cited by 158
Yarmolenko, P., Zhao, Y., Landon, C. D., Spasojević, I., Yuan, F., Needham, D., Viglianti, B. L., & Dewhirst, M. W. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003789284 · Cited by 154
Han, H., SHIN, B., & Choi, H. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.07.006 · Cited by 142
Maruyama, K., Unezaki, S., Takahashi, N., & Iwatsuru, M. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90203-c · Cited by 140
Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats.
Sakaguchi, Y., Stephens, L. C., Makino, M., Kaneko, T., Strebel, F. R., Danhauser, L., Jenkins, G. N., & Bull, J. M. C. (1995) · PubMed · Cited by 137
Bandak, S., Goren, D., Horowitz, A. T., Tzemach, D., & Gabizon, A. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199911000-00007 · Cited by 137
Nomura, T., Koreeda, N., Yamashita, F., Takakura, Y., & Hashida, M. (1998) · Pharmaceutical Research · doi:10.1023/a:1011921324952 · Cited by 135
Thermosensitive polymer-modified liposomes that release contents around physiological temperature
Kono, K., Nakai, R., Morimoto, K., & Takagishi, T. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00226-0 · Cited by 133
Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome
Chen, Q., Tong, S., Dewhirst, M. W., & Yuan, F. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1311.3.10 · Cited by 133
Ta, T., Convertine, A. J., Reyes, C. R., Stayton, P. S., & Porter, T. M. (2010) · Biomacromolecules · doi:10.1021/bm1004993 · Cited by 130
Self-citationChiu, G. N. C., Abraham, S. A., Ickenstein, L. M., Ng, R., Karlsson, G., Edwards, K., Wasan, E. K., & Bally, M. B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.009 · Cited by 130
Chemodosimetry of in vivo tumor liposomal drug concentration using MRI
Viglianti, B. L., Ponce, A. M., Michelich, C. R., Yu, D., Abraham, S. A., Sanders, L. L., Yarmolenko, P., Schroeder, T., MacFall, J. R., Barboriak, D. P., et al. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21032 · Cited by 130
Krishna, R., Webb, M. S., St.-Onge, G., & Mayer, L. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29494-5 · Cited by 129
Kono, K., Nakashima, S., Kokuryo, D., Aoki, I., Shimomoto, H., Aoshima, S., Maruyama, K., Yuba, E., Kojima, C., Harada, A., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.050 · Cited by 123
Handbook of cancer chemotherapy
Griffiths, M. (1996) · European Journal of Cancer Part B Oral Oncology · doi:10.1016/s0964-1955(96)90004-4 · Cited by 120
Banno, B., Ickenstein, L. M., Chiu, G. N. C., Bally, M. B., Thewalt, J. L., Brief, E., & Wasan, E. K. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21988 · Cited by 117
Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancs
Maeda, H., Matsumoto, T., Konno, T., Iwai, K., & Ueda, M. (1984) · Journal of Protein Chemistry · doi:10.1007/bf01040499 · Cited by 115
Unezaki, S., Maruyama, K., Takahashi, N., Koyama, M., Yuda, T., Suginaka, A., & Iwatsuru, M. (1994) · Pharmaceutical Research · doi:10.1023/a:1018949218380 · Cited by 114
Improvement of temperature-sensitivity of poly(N-isopropylacrylamide)-modified liposomes
Kono, K., Henmi, A., Yamashita, H., Hayashi, H., & Takagishi, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00180-1 · Cited by 109
Meshorer, A., Prionas, S. D., Fajardo, L. F., Meyer, J. L., Hahn, G. M., & Martinez, A. A. (1983) · PubMed · Cited by 104
An update on the anticancer effects of a combination of chemotherapy and hyperthermia.
Bull, J. M. (1984) · PubMed · Cited by 98
Allen, T. M., Newman, M. S., Woodle, M. C., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620215 · Cited by 79
SANDSTROM, M., Ickenstein, L. M., Mayer, L. D., & Edwards, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.001 · Cited by 77
Paasonen, L., Romberg, B., Storm, G., Yliperttula, M. L., Urtti, A. O., & Hennink, W. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700245p · Cited by 74
García, A. A., Kempf, R. A., Rogers, M., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008439013169 · Cited by 71
Polozova, A., & Winnik, F. M. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00025-4 · Cited by 59
Patel, P. R., Luk, A., Durrani, A. M., Dromi, S. A., Cuesta, J., Angstadt, M., Dreher, M. R., Wood, B. J., & Frenkel, V. (2008) · International Journal of Hyperthermia · doi:10.1080/02656730802064621 · Cited by 58
Protein-polymer nano-machines. Towards synthetic control of biological processes
Pennadam, S. S., Firman, K., Alexander, C., & Górecki, D. C. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-8 · Cited by 58
Staruch, R., Chopra, R., & Hynynen, K. (2012) · Radiology · doi:10.1148/radiol.11111189 · Cited by 57
Beaumier, P. L., & Hwang, K. J. (1983) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(83)90393-0 · Cited by 56
Bassett, J. B., Anderson, R. U., & Tacker, J. R. (1986) · The Journal of Urology · doi:10.1016/s0022-5347(17)45761-2 · Cited by 50
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.
Ellerhorst, J. A., Bedikian, A. Y., Ring, S. E., Buzaid, A. C., Eton, O. E., & Legha, S. S. (1999) · Oncology Reports · doi:10.3892/or.6.5.1097 · Cited by 49
Yoshino, K., Kadowaki, A., Takagishi, T., & Kono, K. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034205j · Cited by 47
Enhanced Anticancer Therapy Mediated by Specialized Liposomes
Dass, C. R., Walker, T., Burton, M. A., & Decruz, E. E. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06025.x · Cited by 46
Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver.
Iwai, K., Maeda, H., Konno, T., Matsumura, Y., Yamashita, R., Yamasaki, K., Hirayama, S., & Miyauchi, Y. (1987) · PubMed · Cited by 46
Iga, K., Hamaguchi, N., Igari, Y., Ogawa, Y., Gotoh, K., Ootsu, K., Toguchi, H., & Shimamoto, T. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24786-3 · Cited by 38
Nibu, Y., Inoue, T., & Motoda, I. (1995) · Biophysical Chemistry · doi:10.1016/0301-4622(95)00041-u · Cited by 33
Torchilin, V. P. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0881-9_11 · Cited by 31
Zou, Y., Ueno, M., Yamagishi, M., Horikoshi, I., Yamashita, I., Tazawa, K., & Gu, X. (1990) · Selective Cancer Therapeutics · doi:10.1089/sct.1990.6.119 · Cited by 26
Nanoscale Drug Delivery Vehicles for Solid Tumors
Needham, D., & Ponce, A. (2006) · CRC Press eBooks · doi:10.1201/9781420006636.ch34 · Cited by 11
Ojugo (1999) · doi:10.1002/(sici)1099-1492(199912)12:8
(1989) · PubMed
Cited by
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Metadata
- Authors
- Ta, T., & Porter, T. M.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 169
- Issue
- 1-2
- Pages
- 112-125
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2000568918
- Cited by
- 403
- References
- 122
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.